$0.3133
0.008202.69%
At close: -
$0.3115
-0.00180-0.57%
After Hours: Jun 6, 7:42 PM EDT
Comments
Loading...
FibroGen Insider Trading Activity | NASDAQ:FGEN | Benzinga
Track the latest FibroGen insider trading activity. Stay informed on recent buys, sells, and market impact for FibroGen stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are FibroGen Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On March 24, 2025, James Schoeneck, the company's - purchased 300K shares for $0.35 each.
- On March 25, 2025, Thane Wettig, the company's CEO purchased 145K shares for $0.35 each.
Ownership Statistics for FibroGen Inc
Shares Outstanding
101.044M
Insider Shares Owned
6.024M
Insider Percentage Owned
5.96%
Institutional Shares Held
12.792M
Institutional Percentage Held
12.7%
| Mar 25, 2025 | Thane Wettig | CEO | 145.00K | $0.35 | $50.66K | BUY | 36.31% | 544.33K | Mar 24 | View |
| Mar 24, 2025 | James Schoeneck | — | 300.00K | $0.35 | $105.04K | BUY | 292.72% | 402.49K | Mar 20 - Mar 21 | View |
| Jun 13, 2024 | Deyaa Adib | CHIEF MEDICAL OFFICER | 22.12K | $1.17 | $25.88K | BUY | 36.87% | 82.12K | Jun 12 | View |
| Mar 11, 2024 | Thane Wettig | CEO | 50.00K | $1.91 | $95.47K | BUY | 11.87% | 471.18K | Mar 07 | View |
| Sep 06, 2023 | William Jeffrey Henderson | DIRECTOR | -2.00K | $1.03 | -$2.06K | SELL | -6.48% | 28.87K | Sep 01 | View |
| Aug 08, 2023 | William Jeffrey Henderson | DIRECTOR | -2.00K | $1.91 | -$3.82K | SELL | -6.09% | 30.87K | Aug 04 | View |
| Jul 13, 2023 | William Jeffrey Henderson | DIRECTOR | -2.00K | $2.69 | -$5.38K | SELL | -5.74% | 32.87K | Jul 11 | View |
| Jul 10, 2023 | Enrique Conterno | CHIEF EXECUTIVE OFFICER | -1.88K | $2.80 | -$5.26K | SELL | -0.46% | 402.52K | Jul 07 | View |
| Jun 26, 2023 | Thane Wettig | CHIEF COMMERCIAL OFFICER | -791.00 | $16.53 | -$13.07K | SELL | -0.73% | 108.26K | Jun 23 | View |
| Jun 15, 2023 | Christine Chung | SVP, CHINA OPERATIONS | -12.50K | $17.19 | -$214.93K | SELL | -5.02% | 236.33K | Jun 13 - Jun 14 | View |
| Jun 09, 2023 | Benjamin Cravatt | DIRECTOR | 4.34K | $17.17 | -$67.72K | GRANT | 17.81% | 28.74K | Jun 07 - Jun 09 | View |
| Jun 09, 2023 | Aoife Brennan | DIRECTOR | 3.56K | $17.19 | -$81.37K | GRANT | 14.58% | 27.95K | Jun 07 - Jun 09 | View |
| Jun 09, 2023 | Suzanne Blaug | DIRECTOR | -231.00 | $17.20 | -$146.57K | SELL | -0.77% | 29.59K | Jun 07 - Jun 09 | View |
| Jun 09, 2023 | Maykin Ho | DIRECTOR | -231.00 | $17.44 | -$148.59K | SELL | -0.73% | 31.50K | Jun 07 - Jun 08 | View |
| Jun 09, 2023 | JEFFREY EDWARDS | DIRECTOR | 400.00 | $17.19 | -$135.62K | GRANT | 1.19% | 33.98K | Jun 07 - Jun 09 | View |
| Jun 09, 2023 | William Jeffrey Henderson | DIRECTOR | 1.29K | $17.46 | -$122.19K | GRANT | 3.84% | 34.87K | Jun 07 - Jun 08 | View |
| Jun 09, 2023 | James Schoeneck | DIRECTOR | 1.19K | $18.03 | -$127.99K | GRANT | 1.64% | 73.72K | Jun 07 | View |
| Jun 09, 2023 | Thane Wettig | CHIEF COMMERCIAL OFFICER | -1.76K | $17.04 | -$29.95K | SELL | -1.55% | 111.39K | Jun 07 | View |
| Jun 09, 2023 | Juan Graham | CHIEF FINANCIAL OFFICER | -1.78K | $16.99 | -$30.32K | SELL | -2.45% | 71.08K | Jun 07 | View |
| Jun 09, 2023 | Christine Chung | SVP, CHINA OPERATIONS | -3.63K | $17.04 | -$61.89K | SELL | -1.44% | 248.83K | Jun 07 | View |
| Jun 09, 2023 | Mark Eisner | EVP, CHIEF MEDICAL OFFICER | -2.04K | $17.04 | -$34.79K | SELL | -1.24% | 162.86K | Jun 07 | View |
| Jun 09, 2023 | Enrique Conterno | CHIEF EXECUTIVE OFFICER | -8.90K | $17.04 | -$151.58K | SELL | -2.15% | 404.40K | Jun 07 | View |
| Jun 05, 2023 | Mark Eisner | EVP, CHIEF MEDICAL OFFICER | -1.09K | $18.83 | -$20.52K | SELL | -0.66% | 164.90K | Jun 02 | View |
| Apr 11, 2023 | Enrique Conterno | CHIEF EXECUTIVE OFFICER | -1.87K | $19.52 | -$36.48K | SELL | -0.45% | 410.80K | Apr 10 | View |
| Apr 06, 2023 | Mark Eisner | CHIEF MEDICAL OFFICER | -9.18K | $18.78 | -$172.47K | SELL | -5.24% | 165.99K | Apr 04 | View |
| Apr 06, 2023 | Christine Chung | SVP, CHINA OPERATIONS | -6.59K | $18.78 | -$123.79K | SELL | -2.54% | 252.46K | Apr 04 | View |
| Mar 24, 2023 | Thane Wettig | CHIEF COMMERCIAL OFFICER | -905.00 | $18.71 | -$16.93K | SELL | -0.81% | 110.65K | Mar 23 | View |
| Mar 10, 2023 | Christine Chung | SVP, CHINA OPERATIONS | -823.00 | $20.70 | -$330.36K | SELL | -0.32% | 259.05K | Mar 08 - Mar 10 | View |
| Mar 10, 2023 | Enrique Conterno | CHIEF EXECUTIVE OFFICER | 4.09K | $20.62 | -$1.16M | GRANT | 1.00% | 412.67K | Mar 08 - Mar 10 | View |
| Mar 10, 2023 | Mark Eisner | CHIEF MEDICAL OFFICER | 2.68K | $20.60 | -$360.57K | GRANT | 1.55% | 175.18K | Mar 08 - Mar 10 | View |
| Mar 10, 2023 | Juan Graham | CHIEF FINANCIAL OFFICER | -94.00 | $20.54 | -$157.37K | SELL | -0.13% | 72.87K | Mar 08 - Mar 10 | View |
| Mar 10, 2023 | Thane Wettig | CHIEF COMMERCIAL OFFICER | 1.20K | $20.63 | -$287.43K | GRANT | 1.09% | 111.56K | Mar 08 - Mar 10 | View |
| Mar 06, 2023 | Mark Eisner | CHIEF MEDICAL OFFICER | -1.19K | $21.87 | -$25.96K | SELL | -0.68% | 172.50K | Mar 02 | View |
| Jan 10, 2023 | Enrique Conterno | CHIEF EXECUTIVE OFFICER | -1.54K | $19.95 | -$30.68K | SELL | -0.47% | 323.28K | Jan 06 | View |
| Dec 28, 2022 | Thane Wettig | CHIEF COMMERCIAL OFFICER | -734.00 | $15.80 | -$11.60K | SELL | -0.82% | 89.16K | Dec 23 | View |
| Dec 15, 2022 | Juan Graham | CHIEF FINANCIAL OFFICER | -5.74K | $14.89 | -$85.50K | SELL | -10.27% | 50.15K | Dec 08 | View |
| Dec 14, 2022 | Juan Graham | CHIEF FINANCIAL OFFICER | -2.19K | $14.64 | -$32.04K | SELL | -3.91% | 53.70K | Dec 09 - Dec 12 | View |
| Dec 09, 2022 | Christine Chung | SVP, CHINA OPERATIONS | -1.10K | $15.79 | -$17.31K | SELL | -0.46% | 237.71K | Dec 08 | View |
| Dec 09, 2022 | Thane Wettig | CHIEF COMMERCIAL OFFICER | -382.00 | $15.79 | -$6.03K | SELL | -0.42% | 89.90K | Dec 08 | View |
| Dec 09, 2022 | Enrique Conterno | CHIEF EXECUTIVE OFFICER | -2.54K | $15.79 | -$40.15K | SELL | -0.78% | 324.82K | Dec 08 | View |
| Sep 17, 2021 | THOMAS KEARNS JR | DIRECTOR | -13.10K | $11.58 | -$151.71K | SELL | -8.57% | 139.76K | Sep 15 | View |
| Aug 30, 2021 | Thane Wettig | CHIEF COMMERCIAL OFFICER | 3.10K | $11.53 | $35.74K | BUY | 6.78% | 48.82K | Aug 26 | View |
| Jun 17, 2021 | Pat Cotroneo | SVP, FINANCE AND CFO | -4.05K | $25.62 | -$103.84K | SELL | -1.44% | 276.68K | Jun 15 | View |
| Mar 15, 2021 | THOMAS KEARNS JR | DIRECTOR | 0.00 | $19.26 | -$567.36K | SELL-OPTIONS | 0.00% | 258.16K | Mar 11 | View |
| Feb 19, 2021 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $40.52 | -$142.48K | SELL-OPTIONS | 0.00% | 33.10K | Feb 17 | View |
| Jan 21, 2021 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $31.22 | -$145.98K | SELL-OPTIONS | 0.00% | 33.10K | Jan 19 | View |
| Jan 15, 2021 | Kalevi Kurkijarvi | DIRECTOR | 0.00 | $29.55 | -$125.92K | SELL-OPTIONS | 0.00% | 33.10K | Jan 14 | View |
| Dec 30, 2020 | Kalevi Kurkijarvi | — | 0.00 | $29.37 | -$132.40K | OPTION EXERCISE | 0.00% | 33.10K | Dec 28 | View |
| Dec 17, 2020 | Peony Yu | — | -3.35K | $41.61 | -$139.39K | SELL | -1.71% | 192.29K | Dec 16 | View |
| Dec 17, 2020 | Pat Cotroneo | — | -3.07K | $43.60 | -$133.76K | SELL | -1.14% | 266.14K | Dec 15 | View |
| Sep 18, 2020 | Peony Yu | — | -3.35K | $44.01 | -$147.48K | SELL | -1.66% | 198.93K | Sep 16 | View |
| Sep 17, 2020 | Pat Cotroneo | — | -3.07K | $43.63 | -$133.94K | SELL | -1.12% | 272.23K | Sep 15 | View |
| Sep 04, 2020 | Peony Yu | — | 0.00 | $34.45 | -$328.90K | OPTION EXERCISE | 0.00% | 205.58K | Sep 03 | View |
| Sep 04, 2020 | Pat Cotroneo | — | 0.00 | $37.10 | -$414.27K | OPTION EXERCISE | 0.00% | 278.31K | Sep 03 | View |
| Aug 11, 2020 | Pat Cotroneo | — | 7.25K | $33.61 | -$509.56K | OPTION EXERCISE | 2.67% | 278.31K | Aug 07 - Aug 11 | View |
| Jul 28, 2020 | Peony Yu | — | -3.35K | $42.35 | -$141.91K | SELL | -1.60% | 205.58K | Jul 24 | View |
| Jun 18, 2020 | Pat Cotroneo | — | -3.93K | $39.68 | -$155.86K | SELL | -1.43% | 271.06K | Jun 16 | View |
| Jun 12, 2020 | Enrique Conterno | — | 27.80K | $35.57 | $988.88K | PURCHASE | 46.33% | 87.80K | Jun 10 - Jun 11 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
